These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 24247291

  • 21. Atrial fibrillation: Risk of bleeding with dabigatran versus warfarin particularly high in CKD.
    Carney EF.
    Nat Rev Nephrol; 2015 Jan; 11(1):3. PubMed ID: 25421829
    [No Abstract] [Full Text] [Related]

  • 22. Patient Characteristics and Risk of Bleeding With Dabigatran in Atrial Fibrillation.
    Henriksen DP, Hansen MR, Damkier P.
    JAMA Intern Med; 2015 Jul; 175(7):1245. PubMed ID: 26146921
    [No Abstract] [Full Text] [Related]

  • 23. Dosage of Dabigatran as a Risk Factor for Bleeding in Atrial Fibrillation.
    Liu S, Kim CO, Lucyk SN.
    JAMA Intern Med; 2015 Jul; 175(7):1244-5. PubMed ID: 26146920
    [No Abstract] [Full Text] [Related]

  • 24. The Role of Selection in the Risk of Bleeding With Dabigatran in Patients With Atrial Fibrillation.
    Klil-Drori A, Azoulay L.
    JAMA Intern Med; 2015 Jul; 175(7):1243-4. PubMed ID: 26146918
    [No Abstract] [Full Text] [Related]

  • 25. Plasma dabigatran activity one week after discontinuation despite normal renal function.
    Thachil J, Pike G, Keighley-Jones L, Nash MJ.
    Am J Med; 2013 Aug; 126(8):e5-6. PubMed ID: 23800582
    [No Abstract] [Full Text] [Related]

  • 26. Bleeding in Patients of African Ancestry Using Dabigatran: A Potential Effect of Creatine Kinase.
    Horjus DL, van Montfrans GA, Brewster LM.
    JAMA Intern Med; 2015 Jul; 175(7):1243. PubMed ID: 26146917
    [No Abstract] [Full Text] [Related]

  • 27. [New anticoagulants, new emergencies?].
    Djalali S.
    Praxis (Bern 1994); 2013 Jul 24; 102(15):945-6. PubMed ID: 23876694
    [No Abstract] [Full Text] [Related]

  • 28. Gastrointestinal bleeding under dabigatran.
    Stöllberger C, Lindner K, Finsterer J.
    J Postgrad Med; 2014 Jul 24; 60(2):192-3. PubMed ID: 24823522
    [Abstract] [Full Text] [Related]

  • 29. Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.
    Berger R, Salhanick SD, Chase M, Ganetsky M.
    Ann Emerg Med; 2013 Apr 24; 61(4):475-9. PubMed ID: 23522810
    [Abstract] [Full Text] [Related]

  • 30. One-Year Risk of Bleeding With Dabigatran in Patients With Atrial Fibrillation: Placing Real-World Results Into Perspective.
    Miyares MA.
    JAMA Intern Med; 2015 Jul 24; 175(7):1242-3. PubMed ID: 26146916
    [No Abstract] [Full Text] [Related]

  • 31. Complications associated with oral anticoagulation therapy.
    Howard PK.
    Adv Emerg Nurs J; 2013 Jul 24; 35(4):283-6. PubMed ID: 24176826
    [Abstract] [Full Text] [Related]

  • 32. Anticoagulation-associated upper gastrointestinal haemorrhage.
    Bell S, Nand J, Dawes M.
    Intern Med J; 2013 Aug 24; 43(8):952. PubMed ID: 23919341
    [No Abstract] [Full Text] [Related]

  • 33. Comment on ''gastrointestinal bleeding under dabigatran''.
    Gélisse P, Crespel A.
    J Postgrad Med; 2014 Aug 24; 60(4):413-4. PubMed ID: 25370556
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
    Healey JS, Eikelboom J, Douketis J, Wallentin L, Oldgren J, Yang S, Themeles E, Heidbuchel H, Avezum A, Reilly P, Connolly SJ, Yusuf S, Ezekowitz M, RE-LY Investigators.
    Circulation; 2012 Jul 17; 126(3):343-8. PubMed ID: 22700854
    [Abstract] [Full Text] [Related]

  • 40. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.
    Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, Yang S, Alings M, Kaatz S, Hohnloser SH, Diener HC, Franzosi MG, Huber K, Reilly P, Varrone J, Yusuf S.
    Circulation; 2011 May 31; 123(21):2363-72. PubMed ID: 21576658
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.